WALL STREET ASSOCIATES - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 46 filers reported holding NEOS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WALL STREET ASSOCIATES ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$983,000
-29.1%
149,3430.0%0.34%
-39.5%
Q2 2016$1,386,000
-14.0%
149,3430.0%0.55%
-17.2%
Q1 2016$1,611,000
-24.7%
149,3430.0%0.67%
+11.1%
Q4 2015$2,139,000
-48.9%
149,343
-25.1%
0.60%
-24.8%
Q3 2015$4,188,000199,3430.80%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Sio Capital Management, LLC 666,729$14,008,0009.60%
DSC Advisors, L.P. 907,358$17,157,0008.33%
DAFNA Capital Management LLC 63,400$1,332,0001.32%
WALL STREET ASSOCIATES 199,343$4,188,0000.80%
Perceptive Advisors 742,132$15,592,0000.62%
EMERALD MUTUAL FUND ADVISERS TRUST 331,142$6,957,0000.46%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 458,332$9,630,0000.37%
EMERALD ADVISERS, LLC 321,313$6,751,0000.35%
Tourbillon Capital Partners, L.P. 611,686$12,852,0000.34%
DSC Advisors, L.P. 31,240$656,0000.32%
View complete list of NEOS THERAPEUTICS INC shareholders